litlas
ログインアカウント作成

Paul F. Schellhammer

1976–2020 年に発表

別表記
Paul F Schellhammer
60
論文数
21,164
被引用数
59
h 指数
59
i10 指数

被引用数

Paul F. Schellhammer の年別被引用数1980 年: 被引用 2 件1984 年: 被引用 1 件1985 年: 被引用 1 件1986 年: 被引用 1 件1987 年: 被引用 3 件1988 年: 被引用 10 件1989 年: 被引用 6 件1990 年: 被引用 4 件1991 年: 被引用 18 件1992 年: 被引用 11 件1993 年: 被引用 23 件1994 年: 被引用 16 件1995 年: 被引用 22 件1996 年: 被引用 29 件1997 年: 被引用 37 件1998 年: 被引用 46 件1999 年: 被引用 41 件2000 年: 被引用 41 件2001 年: 被引用 46 件2002 年: 被引用 85 件2003 年: 被引用 144 件2004 年: 被引用 165 件2005 年: 被引用 137 件2006 年: 被引用 119 件2007 年: 被引用 129 件2008 年: 被引用 94 件2009 年: 被引用 112 件2010 年: 被引用 137 件2011 年: 被引用 191 件2012 年: 被引用 166 件2013 年: 被引用 224 件2014 年: 被引用 226 件2015 年: 被引用 187 件2016 年: 被引用 178 件2017 年: 被引用 154 件2018 年: 被引用 135 件2019 年: 被引用 448 件2020 年: 被引用 437 件2021 年: 被引用 487 件2022 年: 被引用 305 件2023 年: 被引用 249 件2024 年: 被引用 365 件2025 年: 被引用 142 件2026 年: 被引用 4 件1981〜1983 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,450 件、この内訳の 33.1%中国: 引用元論文 445 件、この内訳の 6%イギリス: 引用元論文 442 件、この内訳の 6%ドイツ: 引用元論文 433 件、この内訳の 5.8%カナダ: 引用元論文 357 件、この内訳の 4.8%イタリア: 引用元論文 323 件、この内訳の 4.4%フランス: 引用元論文 301 件、この内訳の 4.1%オランダ: 引用元論文 271 件、この内訳の 3.7%オーストラリア: 引用元論文 210 件、この内訳の 2.8%ベルギー: 引用元論文 184 件、この内訳の 2.5%日本: 引用元論文 175 件、この内訳の 2.4%スイス: 引用元論文 172 件、この内訳の 2.3%
0%33.1%その他 22.1%

機関

分野

  • Medicine66.6%
  • Immunology and Microbiology14.5%
  • Biochemistry, Genetics and Molecular Biology8.9%
  • Chemistry5.6%
  • Engineering1%
  • Computer Science0.9%
  • その他2.5%

トピック

  • Prostate Cancer Treatment and Research14.4%
  • Prostate Cancer Diagnosis and Treatment10.8%
  • Immunotherapy and Immune Responses7.9%
  • Cancer Immunotherapy and Biomarkers5.9%
  • Radiopharmaceutical Chemistry and Applications3.6%
  • Bladder and Urothelial Cancer Treatments3.2%
  • その他54.2%

共著者

全論文

検索で開く
  1. Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

    著者: Philip W. Kantoff, Celestia S. Higano, Neal D. Shore, E. Roy Berger, Eric J. Small, David F. Penson, Charles H. Redfern, Anna C. Ferrari, Robert Dreicer, Robert B. Sims, Yi Xu, Mark W. Frohlich, Paul F. Schellhammer - New England Journal of Medicine 2010 被引用: 5,492

  2. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference

    著者: Mack Roach, Gerald E. Hanks, Howard D. Thames, Paul F. Schellhammer, William U. Shipley, Gerald H. Sokol, Howard M. Sandler - International Journal of Radiation Oncology*Biology*Physics 2006 被引用: 2,733

  3. Intermittent versus Continuous Androgen Deprivation in Prostate Cancer

    著者: Maha Hussain, Catherine M. Tangen, Donna L. Berry, Celestia S. Higano, E. David Crawford, Glenn Liu, George Wilding, Stephen M. Prescott, S.K. Sundaram, Eric J. Small, Nancy A. Dawson, Bryan Donnelly, Peter Venner, Ulka N. Vaishampayan, Paul F. Schellhammer, David I. Quinn, Derek Raghavan, Benjamin Ely, Carol M. Moinpour, Nicholas J. Vogelzang, Ian M. Thompson - New England Journal of Medicine 2013 被引用: 568

  4. Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues

    著者: George L. Wright, Cara Haley, Mary Lou Beckett, Paul F. Schellhammer - Urologic Oncology Seminars and Original Investigations 1995 被引用: 589

  5. Placebo-Controlled Phase III Trial of Immunologic Therapy with Sipuleucel-T (APC8015) in Patients with Metastatic, Asymptomatic Hormone Refractory Prostate Cancer

    著者: Eric J. Small, Paul F. Schellhammer, Celestia S. Higano, Charles H. Redfern, John Nemunaitis, Frank H. Valone, Suleman Verjee, Lori Jones, Robert M. Hershberg - Journal of Clinical Oncology 2006 被引用: 1,107

  6. Intermittent Androgen Suppression for Rising PSA Level After Radiotherapy

    著者: Juanita Crook, Christopher J. O’Callaghan, Graeme Duncan, David P. Dearnaley, Celestia S. Higano, Eric M. Horwitz, Eliot Frymire, Shawn Malone, Joseph L. Chin, Abdenour Nabid, Padraig Warde, Thomas Corbett, Steve Angyalfi, S. Larry Goldenberg, Mary Gospodarowicz, Fred Saad, John Logue, Emma Hall, Paul F. Schellhammer, Keyue Ding, Laurence Klotz - New England Journal of Medicine 2012 被引用: 497

  7. Integrated data from 2 randomized, double‐blind, placebo‐controlled, phase 3 trials of active cellular immunotherapy with sipuleucel‐T in advanced prostate cancer

    著者: Celestia S. Higano, Paul F. Schellhammer, Eric J. Small, Patrick A. Burch, John Nemunaitis, Lianng Yuh, Nicole Provost, Mark W. Frohlich - Cancer 2009 被引用: 812

  8. Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry

    著者: Oliver Sartor, Andrew J. Armstrong, Chiledum Ahaghotu, David G. McLeod, Matthew R. Cooperberg, David F. Penson, Philip W. Kantoff, Nicholas J. Vogelzang, Arif Hussain, Christopher Pieczonka, Neal D. Shore, David I. Quinn, Eric J. Small, Elisabeth I. Heath, Ronald Tutrone, Paul F. Schellhammer, Matthew Harmon, Nancy N. Chang, Nadeem A. Sheikh, Bruce Alan Brown, Stephen J. Freedland, Celestia S. Higano - Prostate Cancer and Prostatic Diseases 2020 被引用: 143

  9. Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy

    著者: George L. Wright, B. Mayer Grob, Cara Haley, Katie Grossman, Kathy Newhall, Daniel P. Petrylak, John K. Troyer, Alice M. Konchuba, Paul F. Schellhammer, Richard P. Moriarty - Urology 1996 被引用: 630

  10. Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens

    著者: E. David Crawford, Paul F. Schellhammer, David G. McLeod, Judd W. Moul, Celestia S. Higano, Neal D. Shore, Louis Denis, Peter Iversen, Mario A. Eisenberger, Fernand Labrie - The Journal of Urology 2018 被引用: 148

  11. Lower Baseline Prostate-specific Antigen Is Associated With a Greater Overall Survival Benefit From Sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) Trial

    著者: Paul F. Schellhammer, Gerald W. Chodak, James B. Whitmore, Robert B. Sims, Mark W. Frohlich, Philip W. Kantoff - Urology 2013 被引用: 242

  12. Sipuleucel-T

    著者: Celestia S. Higano, Eric J. Small, Paul F. Schellhammer, Uma Yasothan, Steven I. Gubernick, Peter Kirkpatrick, Philip W. Kantoff - Nature Reviews Drug Discovery 2010 被引用: 145

  13. Guideline for the Management of Nonmuscle Invasive Bladder Cancer (Stages Ta, T1, and Tis): 2007 Update

    著者: M. Craig Hall, Sam S. Chang, Guido Dalbagni, Raj S. Pruthi, John D. Seigne, Eila C. Skinner, J. Stuart Wolf, Paul F. Schellhammer - The Journal of Urology 2007 被引用: 839

  14. Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study

    著者: Stephen H. Culp, Paul F. Schellhammer, Michael B. Williams - European Urology 2013 被引用: 432

  15. Improved detection of recurrent bladder cancer using the bard bta stat test

    著者: Michael F. Sarosdy, M’Liss A. Hudson, William J. Ellis, Mark S. Soloway, Ralph Devere White, Joel Sheinfeld, Mark V. Jarowenko, Paul F. Schellhammer, Edward Schervish, Jaymit Patel, Gerald W. Chodak, Donald L. Lamm, Robert D. Johnson, Mary Henderson, George W. Adams, Brent A. Blumenstein, K.R. Thoelke, R.D. Pfalzgraf, H. A. Murchison, Sharon L Brunelle - Urology 1997 被引用: 202

  16. Randomized Trial of Autologous Cellular Immunotherapy with Sipuleucel-T in Androgen-Dependent Prostate Cancer

    著者: Tomasz M. Beer, Guy T. Bernstein, John M. Corman, L. Michael Glodé, Simon J. Hall, Wayne L. Poll, Paul F. Schellhammer, Lori Jones, Yi Xu, Jelle W. Kylstra, Mark W. Frohlich - Clinical Cancer Research 2011 被引用: 135

  17. Role of Estrogen in Normal Male Function: Clinical Implications for Patients With Prostate Cancer on Androgen Deprivation Therapy

    著者: Erik Wibowo, Paul F. Schellhammer, Richard J. Wassersug - The Journal of Urology 2010 被引用: 84

  18. Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: Final report of a double-blind, randomized, multicenter trial

    著者: Paul F. Schellhammer, Roohollah Sharifi, Norman L. Block, Mark S. Soloway, Peter Venner, Anthony L. Patterson, Michael F. Sarosdy, Nicholas J. Vogelzang, Julie Jones Schellenger, Geert J.C.M. Kolvenbag - Urology 1997 被引用: 148

  19. Glycomic Characterization of Prostate-Specific Antigen and Prostatic Acid Phosphatase in Prostate Cancer and Benign Disease Seminal Plasma Fluids

    著者: Krista Y. White, Lucy Rodemich, Julius O. Nyalwidhe, Mary Ann Comunale, Mary Ann Clements, Raymond S. Lance, Paul F. Schellhammer, Anand S. Mehta, O. John Semmes, Richard R. Drake - Journal of Proteome Research 2009 被引用: 90

  20. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

    著者: Bao-Ling Adam, Yinsheng Qu, John W. Davis, Michael D. Ward, Mary Ann Clements, Lisa H. Cazares, O. John Semmes, Paul F Schellhammer, Yutaka Yasui, Ziding Feng, George L Wright - 2002 被引用: 614

  21. Goserelin versus orchiectomy in the treatment of advanced prostate cancer: Final results of a randomized trial

    著者: Nicholas J. Vogelzang, Gerald W. Chodak, Mark S. Soloway, Norman L. Block, Paul F. Schellhammer, Joseph A. Smith, Richard Caplan, Gerard T. Kennealey - Urology 1995 被引用: 173

  22. Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group study

    著者: Donald L. Lamm, Brent A. Blumenstein, E. David Crawford, John D. Crissman, Bruce A. Lowe, Joseph A. Smith, Michael F. Sarosdy, Paul F. Schellhammer, Arthur I. Sagalowsky, Edward M. Messing, P. Loehrer, H. Barton Grossman - Urologic Oncology Seminars and Original Investigations 1995 被引用: 142

  23. Laparoscopic Radical Prostatectomy: Decreasing the Learning Curve Using A Mentor Initiated Approach

    著者: Michael D. Fabrizio, Ingolf Tuerk, Paul F. Schellhammer - The Journal of Urology 2003 被引用: 136

  24. Pulmonary metastases from prostate cancer

    著者: Scott J. Fabozzi, Paul F. Schellhammer, Anas M. El-Mahdi - Cancer 1995 被引用: 93